MS-STAT2 finally takes off

16 May, 2017 | Posted in:

by Professor Gavin Giovannoni Finally a phase 3 trial in progressive MS is being done outside of Big Pharma. Great news for people with progressive MS. We will now get an answer about whether or not simvastatin works in a larger study, its safety profile and more importantly its risk:benefit profile in people with more […]

Continue Reading »

Audit of MS relapse management in a district general hospital setting

4 May, 2017 | Posted in:

by Dr Ferghal McVerry, Consultant Neurologist, Altnagelvin Hospital Dr Ferghal McVerry is the winner of the first Multiple Sclerosis Academy MasterClass Project Award for his audit of multiple sclerosis relapse management in a district general hospital setting. The intermodule project is an integral part of the MasterClass. Course participants choose an area of interest which might be […]

Continue Reading »

#NeuroSpeak: education, education, education…

5 April, 2017 | Posted in:

by Prof Gavin Giovannoni What has Tony Blair got to do with multiple sclerosis? #MSBlog #NeuroSpeak Tony Blair is famously quoted as putting ‘Education, education, education, …’ at the centre of New Labour’s manifesto in 1997. However, it is the type, or quality, of education that makes a difference. I have learnt that information in […]

Continue Reading »

Free opportunities for neurologists to expand understanding of neurology & become an expert in managing MS

3 April, 2017 | Posted in:

Webinar: Neurology in the NHS led by Sue Thomas, CEO, Commissioning Excellence Expert training in MS led by Professor Gavin Giovannoni, Barts Hospital, London The Neurology Academy in partnership with Wilmington Healthcare is delighted to offer members an exceptional free opportunity to understand how neurology services are currently being delivered and/or become an expert in […]

Continue Reading »